Salvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects.

This study was conducted to examine the SM-induced anti-osteoporotic effect and its possible mechanisms with various doses of SM.

Methods: We studied Sprague-Dawley female rats aged 12 weeks, divided into six groups: shamoperated control (SHAM), ovariectomized (OVX), and OVX rats supplemented with SM (1, 3, 10 and 30 mg/kg) orally for 8 weeks. At the end of the experiment, blood samples were collected and biochemistry analysis was performed.

Specimens from both tibia and liver were processed for light microscopic examination. DEXA and mu-CT analyses of the tibia were also performed.

Results: SM treatment significantly ameliorated the decrease in BMD and trabecular bone mass according to DEXA and trabecular bone architecture analysis of trabecular bone structural parameters by mu-CT scanning.

In serum biochemical analysis, SM decreased the released TRAP-5b, an osteoclast activation marker and oxidative stress parameters including MDA and NO induced by OVX.

Conclusions: The preventive effect of SM was presumably due to its anti-oxidative stress partly via modulation of osteoclast maturation and number. In current study, SM appears to be a promising osteoporosis therapeutic natural product.

Author: Yan CuiBidur BhandaryAnu MarahattaGeum-Hwa LeeBo LiDo-Sung KimSoo-Wan ChaeHyung-Ryong KimHan-Jung Chae

source: 7thspace


This is not a company blog or website. The views and statements expressed in this blog are absolutely subjective. All content here is either copyrighted or by the mentioned news sources.

Privacy Policy | Contact Us